Li, Zhijie <br/><br/>
Targeting Akt to increase the sensitivity of neuroblastoma to chemotherapy: lessons learned from the brain-derived neurotrophic factor/TrkB signal transduction pathway.  [electronic resource] 

 -  Expert opinion on therapeutic targets  Dec 2007 
 - 1611-21 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, N.I.H., Intramural; Review 
<br/><br/><label>ISSN: </label>1744-7631 
<br/><br/><label>Standard No.: </label>10.1517/14728222.11.12.1611  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antineoplastic Agents--therapeutic use<br/>Brain-Derived Neurotrophic Factor--metabolism<br/>Humans<br/>Neuroblastoma--drug therapy<br/>Proto-Oncogene Proteins c-akt--antagonists & inhibitors<br/>Receptor, trkB--metabolism<br/>Signal Transduction